MNKD Mannkind Corp

Price (delayed)

$3.8

Market cap

$1.17B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.07

Enterprise value

$1.69B

?
Relative Growth: Rel. Growth: 35
Relative Strength: Rel. Strength: 39
Relative Valuation: Rel. Valuation: 17
Relative Profitability: Rel. Profitability: 31

MannKind Corporation focuses on the development and commercialization of innovative inhaled therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. ...

Highlights
Mannkind's gross profit has increased by 23% YoY and by 4.5% from the previous quarter
The revenue has grown by 21% YoY and by 3.4% from the previous quarter
The company's debt has surged by 97% YoY but it fell by 6% QoQ
Mannkind's net income has plunged by 179% YoY
Mannkind's EPS has plunged by 170% YoY

Key stats

What are the main financial stats of MNKD

MNKD stock price

How has the Mannkind stock price performed over time
Intraday
-2.81%
1 week
-3.8%
1 month
-15.93%
1 year
1.33%
YTD
-32.98%
QTD
-10.8%

Financial performance

How have Mannkind's revenue and profit performed over time
Revenue
$360.78M
Gross profit
$272.87M
Operating income
$18.76M
Net income
-$23.91M
Gross margin
75.6%
Net margin
-6.6%
Mannkind's net income has plunged by 179% YoY
The company's net margin has shrunk by 165% YoY
MNKD's operating margin has dropped by 80% year-on-year and by 61% since the previous quarter
MNKD's operating income has shrunk by 76% YoY and by 60% QoQ

Price vs fundamentals

How does MNKD's price correlate with its fundamentals

Growth

What is Mannkind's growth rate over time

Valuation

What is Mannkind stock price valuation
P/E
N/A
P/B
N/A
P/S
3.25
EV/EBIT
150.08
EV/EBITDA
58.22
EV/Sales
4.68
Mannkind's EPS has plunged by 170% YoY
The equity has declined by 16% since the previous quarter
The P/S is 59% lower than the 5-year quarterly average of 8.0 and 19% lower than the last 4 quarters average of 4.0
The revenue has grown by 21% YoY and by 3.4% from the previous quarter

Efficiency

How efficient is Mannkind business performance
The ROA has shrunk by 156% YoY
Mannkind's ROS has plunged by 87% YoY and by 73% from the previous quarter
The company's return on invested capital has shrunk by 85% YoY and by 74% QoQ

Dividends

What is MNKD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MNKD.

Financial health

How did Mannkind financials performed over time
The company's total assets is 7% lower than its total liabilities
The company's total assets has surged by 81% YoY but it fell by 6% QoQ
MNKD's total liabilities has surged by 71% year-on-year but it is down by 4.7% since the previous quarter
The company's debt has surged by 97% YoY but it fell by 6% QoQ
The debt to equity has dropped by 95% year-on-year but it is up by 19% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.